What is Posit Science?
Posit Science operates at the intersection of neuroscience and digital therapeutics, providing a suite of brain fitness exercises through its flagship platform, BrainHQ. Under the guidance of renowned neuroscientist Dr. Michael Merzenich, the company has established a robust scientific foundation, supported by over 60 peer-reviewed articles that validate the efficacy of its exercises in enhancing brain speed, attention, and memory. Unlike generic cognitive games, Posit Science focuses on neuroplasticity-based training, positioning itself as a critical player in the preventative healthcare and wellness markets. Its market position is further bolstered by extensive media coverage and clinical validation, distinguishing the firm as a high-authority provider in the cognitive health space.
How much funding has Posit Science raised?
Posit Science has raised a total of $985K across 2 funding rounds:
Debt
$350K
Debt
$635K
Debt (2020): $350K with participation from PPP
Debt (2021): $635K led by PPP
Key Investors in Posit Science
PPP
Public-Private Partnership
What's next for Posit Science?
With the recent influx of capital, Posit Science is well-positioned to accelerate its enterprise-level growth strategy. The company is expected to focus on expanding its reach within healthcare systems and corporate wellness programs, where the demand for clinically proven cognitive health tools is rising. Future initiatives will likely involve deepening the integration of its BrainHQ platform into broader digital health ecosystems, potentially exploring new partnerships to enhance user engagement and long-term cognitive outcomes. As the company matures, the focus will remain on maintaining its scientific rigor while scaling its technological infrastructure to meet the needs of an aging global population and those seeking cognitive optimization.
See full Posit Science company page
